MP16-13 INCREASED EXPRESSION OF MUTATED BRCA2 IS ASSOCIATED WITH POOR PROGNOSIS OF PATIENTS WITH HIGH RISK PROSTATE CANCER TREATED WITH DEFINITIVE RADIOTHERAPY

INTRODUCTION AND OBJECTIVE:PARP inhibitor shows activity in metastatic castration-resistant prostate cancer (PC) with BRCA mutation, however, the association of the BRCA mutation with treatment out...